In re Rigel Pharmaceuticals, Inc. Securities Litigation (United States Court of Appeals for the Ninth Circuit)

被引：0

|

作者：

Deleage, Andre

机构：

来源：

BIOTECHNOLOGY LAW REPORT | 2012年 / 31卷 / 06期

关键词：

D O I：

10.1089/blr.2012.9687

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：595 / 606

页数：12

相关论文

共 50 条

[31] The Tenth Circuit rejects selective waiver: Qwest Communications International, Inc. securities litigation
Gegenheimer, Nancy J.
DENVER UNIVERSITY LAW REVIEW, 2007, 84 (03) : 775 - 808
[32] Amarin Pharma, Inc. v. Hikma Pharms. USA, Inc.: United States Court of Appeals of the Federal Circuit, 2024 104 F.4th 1370
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2024, 43 (04) : 224 - 231
[33] Regeneron Pharms., Inc. v. Mylan Pharms. Inc.: United States Court of Appeals of the Federal Circuit, 2025 127 F.4th 896
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2025,
[34] Amarin Pharma, Inc. v. Hikma Pharms. USA Inc.: United States Court of Appeals of the Federal Circuit, 2024 104 F.4th 1370
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2024,
[35] Endo Pharm. Inc. v. Teva Pharm. USA, Inc. United States Court of Appeals of the Federal Circuit, 2019 919 F.3d 1347
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2019, 38 (03) : 177 - 181
[36] Amgen Inc. v. Hospira, Inc. United States Court of Appeals of the Federal Circuit, 2019 No. 2019-1067, 2019 WL 6834390, _F.3d _
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2020, 39 (01) : 47 - 55
[37] Par Pharm., Inc. v. Eagle Pharms., Inc. United States Court of Appeals of the Federal Circuit, 2022 No. 2021-2342, 2022 WL 3449817
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2022, 41 (05) : 258 - 261
[38] REVIEW IN THE SUPREME COURT OF THE UNITED STATES OF, THE DISTRICT COURT AND CIRCUIT COURT OF APPEALS
Bunn, Charles W.
HARVARD LAW REVIEW, 1922, 35 (08) : 902 - 909
[39] Medytox, Inc. v. Galderma SA United States Court of Appeals of the Federal Circuit, 2023 71 F.4th 990
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2023, 42 (06) : 324 - 331
[40] Valeant Pharm. Int'l, Inc. v. Mylan Pharm. Inc. United States Court of Appeals of the Federal Circuit, 2020 955 F.3d 25
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2020, 39 (03) : 256 - 261

← 1 2 3 4 5 →